Trial · NCT07910955
Effects of Balance Training in Individuals With Glaucoma
NCT07910955, Not applicable, Recruiting, Kanuni Sultan Suleyman Training and Research Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effects of Balance Training in Individuals With Glaucoma. Trials, record NCT07910955. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07910955
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effects of Balance Training in Individuals With Glaucoma
- NCT number
- NCT07910955
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 50 participants, estimated
- Lead sponsor
- Kanuni Sultan Suleyman Training and Research Hospital
- Conditions
- Glaucoma
- Interventions
- Balance Training Program
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Balance Performance Assessed by the Berg Balance Scale | Baseline and 8 weeks | Balance performance will be assessed using the Berg Balance Scale (BBS), a 14-item performance-based measure of static and dynamic balance. Each item is scored from 0 to 4, resulting in a total score ranging from 0 to 56. Higher scores indicate better balance performance. The change in BBS score from baseline to the end of the 8-week intervention will be evaluated. |
| Secondary | Change in Functional Mobility and Fall Risk Assessed by the Timed Up and Go Test (TUG) | Baseline and 8 weeks | Functional mobility and fall risk will be assessed using the Timed Up and Go Test (TUG). Participants will be instructed to stand up from a standard chair, walk a distance of 3 meters, turn around, walk back to the chair, and sit down. The time required to complete the test will be recorded in seconds. A longer completion time indicates poorer functional mobility and a higher fall risk. The change in TUG time from baseline to the end of the 8-week intervention will be evaluated. |
| Other | Change in Fear of Falling Assessed by the Falls Efficacy Scale-International (FES-I) | Baseline and 8 weeks | Fear of falling will be assessed using the Falls Efficacy Scale-International (FES-I), a 16-item questionnaire evaluating concern about falling during various daily activities. Each item is scored from 1 to 4, resulting in a total score ranging from 16 to 64. Higher scores indicate greater concern about falling. The change in FES-I score from baseline to the end of the 8-week intervention will be evaluated. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07910955
GET https://conductscience.org/api/trials/v1/NCT07910955/registered